Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma

NCT07648069 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma (STS)
Osteosarcoma

Interventions

BIOLOGICAL: Neoantigen vaccine + specific lymphocytes + anti-PD1 antibody
BIOLOGICAL: Neoantigen vaccine + anti-PD1 antibody

Sponsor

Sun Yat-sen University